By: Tim Povtak From: asbestos.com Neoadjuvant chemotherapy — often used before aggressive surgery — has shown no definitive survival benefit for patients with pleural mesothelioma cancer, according to a recent study at the Duke University Medical Center. The study strengthened the growing belief among mesothelioma specialists that the combination of chemotherapy drugs cisplatin and pemetrexed might be a more effective …
-
-
Why I Can’t Write Your Breast Cancer Story for You
-
Moving to a Distant Location as a Breast Cancer Survivor
-
Getting a Second Opinion After a Breast Cancer Diagnosis
-
Dealing with the Side Effects of Breast Cancer Treatments
-
Why Would You Tell a Breast Cancer Survivor What to Do?
